Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. / Ravnborg, Mads; Bendtzen, K; Christensen, O; Jensen, P E H; Hesse, D; Tovey, M G; Sørensen, P S.

I: Multiple Sclerosis, Bind 15, Nr. 3, 01.03.2009, s. 323-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Ravnborg, M, Bendtzen, K, Christensen, O, Jensen, PEH, Hesse, D, Tovey, MG & Sørensen, PS 2009, 'Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis', Multiple Sclerosis, bind 15, nr. 3, s. 323-8. https://doi.org/10.1177/1352458508099476, https://doi.org/10.1177/1352458508099476

APA

Ravnborg, M., Bendtzen, K., Christensen, O., Jensen, P. E. H., Hesse, D., Tovey, M. G., & Sørensen, P. S. (2009). Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Multiple Sclerosis, 15(3), 323-8. https://doi.org/10.1177/1352458508099476, https://doi.org/10.1177/1352458508099476

Vancouver

Ravnborg M, Bendtzen K, Christensen O, Jensen PEH, Hesse D, Tovey MG o.a. Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Multiple Sclerosis. 2009 mar. 1;15(3):323-8. https://doi.org/10.1177/1352458508099476, https://doi.org/10.1177/1352458508099476

Author

Ravnborg, Mads ; Bendtzen, K ; Christensen, O ; Jensen, P E H ; Hesse, D ; Tovey, M G ; Sørensen, P S. / Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. I: Multiple Sclerosis. 2009 ; Bind 15, Nr. 3. s. 323-8.

Bibtex

@article{02d2d2c05c0f11df928f000ea68e967b,
title = "Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis",
abstract = "It is unknown whether immunosuppression of patients who have developed interferon-beta (IFN-beta) neutralizing antibodies (NAbs) hastens disappearance of NAbs in the blood.",
author = "Mads Ravnborg and K Bendtzen and O Christensen and Jensen, {P E H} and D Hesse and Tovey, {M G} and S{\o}rensen, {P S}",
year = "2009",
month = mar,
day = "1",
doi = "10.1177/1352458508099476",
language = "English",
volume = "15",
pages = "323--8",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "3",

}

RIS

TY - JOUR

T1 - Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

AU - Ravnborg, Mads

AU - Bendtzen, K

AU - Christensen, O

AU - Jensen, P E H

AU - Hesse, D

AU - Tovey, M G

AU - Sørensen, P S

PY - 2009/3/1

Y1 - 2009/3/1

N2 - It is unknown whether immunosuppression of patients who have developed interferon-beta (IFN-beta) neutralizing antibodies (NAbs) hastens disappearance of NAbs in the blood.

AB - It is unknown whether immunosuppression of patients who have developed interferon-beta (IFN-beta) neutralizing antibodies (NAbs) hastens disappearance of NAbs in the blood.

U2 - 10.1177/1352458508099476

DO - 10.1177/1352458508099476

M3 - Journal article

C2 - 19028832

VL - 15

SP - 323

EP - 328

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

SN - 1352-4585

IS - 3

ER -

ID: 19662914